Ullet index:JCR Pharmaceuticals Co.,Ltd.:4552

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index JCR Pharmaceuticals Co.,Ltd. Go to web site 4552 Medicals 東証プライム March 1, 2000 1992.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

JCR Pharmaceuticals Co.,Ltd. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 47,043
plusdown
56,178
plusup
52,162
plusup
50,884
plusup
38,383
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp -4,759
plusdown
5,509
plusup
3,773
plusdown
14,508
plusup
6,893
plus
Operating Cash Flow(OFC)Help -5,485
plusdown
9,312
plusup
-5,499
plusdown
9,289
plusdown
10,340
plus
Free Cash Flow(FCF)Help -15,359
plusdown
6,622
plusup
-20,501
plusdown
6,039
plusdown
7,050
plus
OFC - Net IncomeHelp 66
plusdown
73
plusdown
74
plusdown
80
plusup
74
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp -103.61%
plusdown
35.98%
plusup
-52.24%
plusdown
49.18%
plusdown
56.21%
plus
Current Assets / Amount of SalesHelp 16.01%
plusdown
60.37%
plusup
30.65%
plusdown
36.98%
plusdown
61.14%
plus
Free Cash Revenue RatioHelp -46.44%
plusdown
15.45%
plusup
-59.69%
plusdown
11.82%
plusdown
23.43%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

JCR Pharmaceuticals Co.,Ltd.

Company where related level is highHelp

D.Western Therapeutics Institute, Inc.
MEDICAL & BIOLOGICAL LABORATORIES CO.
GNI Group Ltd.
Veritas In Silico
LTT Bio-Pharma Co.,Ltd.
Eisai Co.,Ltd.
Kringle Pharma,Inc.
Kyowa Kirin Co.,Ltd.
Cuorips Inc.
Sumitomo Pharma Co., Ltd.